Tag: IntegraGen
IntegraGen: turnover falls by 7% in 2023
By Alexandra Saintpierre Published on 01/16/2024 at 6:08 p.m. Photo credit © Boursier.com (Boursier.com) — IntegraGen , a…
Integragen: post-Covid decline in activity in 2023 – 01/16/2024 at 6:27 p.m.
(AOF) – Integragen announced an unaudited turnover of 11.75 million euros in 2023, down 7% compared to 2022. This company specializing in the decryption of the human genome explains this…
Integragen: post-Covid decline in activity in 2023
(AOF) – Integragen announced an unaudited turnover of 11.75 million euros in 2023, down 7% compared to 2022. This company specializing in the decryption of the human genome explains this…
IntegraGen: Results for the first half of 2023 – Revenue down 13% and profitability resilience – 10/19/2023 at 6:15 p.m.
Evry, France, Thursday October 19, 2023, 5:45 p.m. – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), a company of the OncoDNA group specializing in the genomics of cancer and…
IntegraGen: Cash at 4.3 ME
AB Published on 07/13/2023 at 07:42 (Boursier.com) — IntegraGen reveals a turnover of 5.6 MEUR in the first half of…
Integragen: EBITDA is positive at 170 KE
By Claude Leguilloux Published on 04/29/2022 at 6:57 p.m. (Boursier.com) —…
IntegraGen – 2021 annual results: strong growth of 20% in income from current operations and marked improvement in profitability – 04/29/2022 at 18:44
2021 annual results: strong growth of 20% in income from day-to-day operations and marked improvement in profitability • Positive gross operating surplus and net income • Significant increase in services…
IntegraGen: boosted by double-digit annual growth – 01/14/2022 at 11:41
(CercleFinance.com) – IntegraGen shares jumped on the Paris Stock Exchange on Friday, the specialist in cancer genomics and genetic diseases having announced new double-digit growth in its activity in 2021.…